Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Prokidney (PROK) Shares Outstanding (Diluted Average) (2022 - 2025)

Historic Shares Outstanding (Diluted Average) for Prokidney (PROK) over the last 4 years, with Q3 2025 value amounting to $135.0 million.

  • Prokidney's Shares Outstanding (Diluted Average) rose 698.98% to $135.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $135.0 million, marking a year-over-year increase of 698.98%. This contributed to the annual value of $97.9 million for FY2024, which is 5866.07% up from last year.
  • Per Prokidney's latest filing, its Shares Outstanding (Diluted Average) stood at $135.0 million for Q3 2025, which was up 698.98% from $130.7 million recorded in Q2 2025.
  • In the past 5 years, Prokidney's Shares Outstanding (Diluted Average) ranged from a high of $135.0 million in Q3 2025 and a low of $25.6 million during Q2 2022
  • For the 4-year period, Prokidney's Shares Outstanding (Diluted Average) averaged around $82.4 million, with its median value being $63.1 million (2023).
  • Its Shares Outstanding (Diluted Average) has fluctuated over the past 5 years, first soared by 15180.27% in 2023, then tumbled by 95.63% in 2024.
  • Over the past 4 years, Prokidney's Shares Outstanding (Diluted Average) (Quarter) stood at $61.5 million in 2022, then increased by 0.28% to $61.7 million in 2023, then soared by 58.66% to $97.9 million in 2024, then skyrocketed by 37.87% to $135.0 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $135.0 million for Q3 2025, versus $130.7 million for Q2 2025 and $129.0 million for Q1 2025.